Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375036 · ClinicalTrials.gov registry record
Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients
A clinical trial, sponsored by Gilead Sciences.
- Completed
- Registry status
- 510
- Enrollment target
NCT01375036 is a clinical trial that has completed, run by Gilead Sciences. The registered enrollment target is 510 participants.
The verdict
NCT01375036 has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 510 participants
- Enrollment target
Study Summary
This is a prospective, longitudinal, 5-year study that will enroll participants from the existing Cystic Fibrosis Foundation (CFF) patient registry. Each enrolled participant will provide samples for microbiological evaluation, obtained upon enrollment and then once per year thereafter for 5 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375036
The ClinicalTrials.gov registry entry for NCT01375036 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01375036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01375036 about?
NCT01375036 is a clinical study titled "Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients". This is a prospective, longitudinal, 5-year study that will enroll participants from the existing Cystic Fibrosis Foundation (CFF) patient registry. Each enrolled participant will provide samples for microbiological evaluation, obtained upon enrollment and then once per year thereafter for 5 years.
What is the current status of trial NCT01375036?
This trial is currently completed. The enrollment target is 510 participants. The study started on 2011-08. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01375036?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.